|
AU2012200066A1
|
|
Method of enhanced immunogenicity to meningococcal vaccination
|
|
WO2005066333A1
|
|
Stabilizing compositions for recombinant viruses
|
|
WO2005068640A2
|
|
Modified ksa and uses thereof
|
|
WO2004106365A2
|
|
Modulatory peptide motifs for inducing th1 or th2 immune response
|
|
AU2004255526A1
|
|
Method of enhanced immunogenicity to meningococcal vaccination
|
|
CA2524860A1
|
|
Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine
|
|
CA2510229A1
|
|
Production of alvac on avian embryonic stem cells
|
|
WO2004005463A2
|
|
Tumor antigens bfa4 and bcy1 for prevention and/or treatment of cancer
|
|
WO2004033623A2
|
|
Animal component free meningococcal polysaccharide fermentation and seedbank development
|
|
AU2003228339A1
|
|
Prevention and treatment of disease using angiogenesis-and/or tumor antigens
|
|
WO02091998A2
|
|
Novel meningitis conjugate vaccine
|
|
US6146902A
|
|
Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
|
|
US7018637B2
|
|
Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
|
